● Fiscal first-quarterRevenuerose 19% to $92.3 billion, with Azure growth at 48%.
● Fiscal fourth-quarterRevenuerose 379.3% to $54.23 billion on the memory shortage.
● Planned 2026Capitalspending rose to about $27 billion from $20 billion to $25 billion.
● HSBC downgraded Nvidia to Hold, andMarket Valueended near $3.92 trillion.
● Fiscal first-quarterRevenuerose 378% to $11.03 billion, with an 85.1% gross margin.
● Third-quarterRevenuerose 161% to $14.6 billion, withNet Incomeof $4.4 billion.
● Third-quarterRevenuewas flat at $28.05 billion, whileOperating Marginfell to 2.6%.
BioLineRx Ltd. and Hemispherian AS issued an 8-K-style press release on November 16, 2026, announcing the presentation of two GLIX1 posters at the 31st Society for Neuro-Oncology Annual Meeting and disclosing that dosing had been initiated in the fourth cohort of the ongoing Phase …
Xtant Medical Holdings, Inc. (NYSE American:XTNT) reported third-quarter 2026 financial results on November 16, 2026, disclosing a net loss of $3.6 million, year-over-year revenue declines, and the withdrawal of its full-year 2026 financial guidance amid an ongoing Board-led strategic review.
BCLS Fund III Investments, LP filed Amendment No. 3 to a Schedule 13G with the SEC on November 16, 2026, disclosing its beneficial ownership of common stock in Heartflow, Inc. as of September 30, 2026.